These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Hemolysis and primaquine treatment. Preliminary report].
    Author: Menéndez Capote R, Díaz Pérez L, Luzardo Suárez C.
    Journal: Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977.
    Abstract:
    8 patients with paludism diagnosis due to Plasmodium vivax and deficiency of glucose-6-phosphate dehydrogenase that should receive antipaludism radical treatment with primaquine were studied. It was determined that 87.5% of the patients presented hemolysis but its relation with the enzymatic activity was not significant (p > 0.05). 50% of the patients could not finish their treatment because of the appearance of important hemolysis. It is concluded that primaquine should not be used indiscriminately among those patients with deficit of glucose 6 phosphate dehydrogenase.
    [Abstract] [Full Text] [Related] [New Search]